Company profile
Adastra Holdings Ltd.
OTC: XTXXF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Langley, BCCIK 0001891512Reports USD
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 25
v0.1 · 5/100 weight · pillars only
↑ return on assets, Piotroski F · ↓ filing timeliness, listing tenure
Methodology →Revenue TTM
$12.0M
Rev growth YoY (TTM)
-35.7%
Net income (FY)
-$3.3M
Employees
21
as of 2026-08-28
Market cap
$39.2k
as of 2026-08-28
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Net income-$3.3M-4.3M CAD2022
Total assets$23.5M31.8M CAD2022
Liabilities$10.0M13.6M CAD2022
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Adastra Holdings Ltd.’s financial profile?
Adastra Holdings Ltd. earned -$3.3M in FY2022 net income.
Peers · Healthcare
Vincerx Pharma, Inc.——Psyence Biomedical Ltd.——BioTech Medics, Inc.——North Springs Resources Corp——Hemp Naturals, Inc.——Western Sierra Resource Corporation——Key facts
CEOBrian O'Neill
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersLangley, BC
ExchangeOTC: XTXXF
Employees21
IPO date2021-07-19
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.